A Tale of Two Data Businesses: Incyte, Gene Logic Evolve Strategies for Growth | GenomeWeb

Despite declining database revenues, companies peddling biological information remain bullish about their chances for success in the coming year.

Incyte last week reported a 62 percent year-over-year drop in second-quarter revenues, which come primarily from its information business — down to $11.0 million in Q2 2003 from $29.1 million in Q2 2002. Nevertheless, it predicted annual revenues of $50 million to $60 million overall and said it expects to be operating on a cash-flow-neutral or cash-flow-positive basis by the end of the year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.